Insight

Insights,

Government negotiation of prescription drug prices isn’t a panacea for lower costs

Insights,

BCBS ‘Evidence Street’ Group Enabling Engagement With MDx Players

Insights,

Marc Samuels Featured in FierceHealthcare

Insights,

Trump’s healthcare nominees are just what the doctor ordered

Insights,

Roche spends $1 billion on Foundation Medicine’s tumor profiling

Insights,

What’s Next: A Trump Administration

Insights,

ADVI UP CLOSE: The end of the Obama Administration and what to expect next

Insights,

ADVI Analysis PAMA Final Rule

Insights,

Medicare Authorization & CHIP Reauthorization (MACRA)